{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T11:36:35Z","timestamp":1781523395973,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jaut.2025.103401","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T14:20:03Z","timestamp":1743171603000},"page":"103401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Treatment of uveitis in Blau syndrome: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"153","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6418-3254","authenticated-orcid":false,"given":"Ilaria","family":"Maccora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos D.","family":"Ros\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Maniscalco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"de Masi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Vincenza","family":"Mastrolia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Marrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Pagnini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Simonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2025.103401_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1546-0096-12-33","article-title":"Blau syndrome, the prototypic auto-inflammatory granulomatous disease","volume":"12","author":"Wouters","year":"2014","journal-title":"Pediatr. Rheumatol. Online J."},{"issue":"6","key":"10.1016\/j.jaut.2025.103401_bib2","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/rheumatology\/keu437","article-title":"Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes","volume":"54","author":"Ros\u00e9","year":"2015","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.jaut.2025.103401_bib3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4049\/jimmunol.1402330","article-title":"Blau syndrome-associated Nod2 mutation alters expression of full-length NOD2 and limits responses to muramyl dipeptide in knock-in mice","volume":"194","author":"Dugan","year":"2015","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.jaut.2025.103401_bib4","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/13816810.2021.1946701","article-title":"A novel pathogenic NOD2 variant in a mother and daughter with Blau syndrome","volume":"42","author":"Rodrigues","year":"2021","journal-title":"Ophthalmic Genet."},{"issue":"3","key":"10.1016\/j.jaut.2025.103401_bib5","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10792-016-0293-5","article-title":"Adalimumab for the treatment of refractory noninfectious paediatric uveitis","volume":"37","author":"Mu\u00f1oz-Gallego","year":"2017","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.jaut.2025.103401_bib6","first-page":"1","article-title":"Long-term visual outcome of patients with Blau syndrome","author":"Kreps","year":"2024","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.jaut.2025.103401_bib7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ajo.2017.08.017","article-title":"Blau syndrome-associated uveitis: preliminary results from an international prospective interventional case series","volume":"187","author":"Sarens","year":"2018","journal-title":"Am. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.jaut.2025.103401_bib8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/art.25035","article-title":"Thalidomide dramatically improves the symptoms of early-onset sarcoidosis\/Blau syndrome: its possible action and mechanism","volume":"62","author":"Yasui","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2025.103401_bib9","first-page":"617","article-title":"NOD2\/CARD15 gene mutation identified in a Chinese family with Blau syndrome","volume":"18","author":"Xiang","year":"2012","journal-title":"Mol. Vis."},{"issue":"6","key":"10.1016\/j.jaut.2025.103401_bib10","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.ajo.2006.06.064","article-title":"Blau syndrome associated with a CARD15\/NOD2 mutation","volume":"142","author":"Snyers","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.jaut.2025.103401_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.895765","article-title":"Potential benefits of TNF targeting therapy in Blau syndrome, a NOD2-associated systemic autoinflammatory granulomatosis","volume":"13","author":"Matsuda","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2025.103401_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.932919","article-title":"Blau syndrome: lessons learned in a tertiary care centre at Chandigarh, North India","volume":"13","author":"Kumrah","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2025.103401_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4103\/ijo.IJO_671_18","article-title":"Familial Blau syndrome: first molecularly confirmed report from India","volume":"67","author":"Janarthanan","year":"2019","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.jaut.2025.103401_bib14","first-page":"n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clin. Res. Ed.)"},{"issue":"3","key":"10.1016\/j.jaut.2025.103401_bib15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.jaut.2025.103401_bib16","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ajo.2021.03.047","article-title":"Classification criteria for sarcoidosis-associated uveitis","volume":"228","author":"Standardization of Uveitis Nomenclature (Sun) Working Group","year":"2021","journal-title":"Am. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.jaut.2025.103401_bib17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/09273948.2020.1746353","article-title":"Clinical profile in genetically proven Blau syndrome: a case series from south India","volume":"29","author":"Babu","year":"2021","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"5","key":"10.1016\/j.jaut.2025.103401_bib18","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaapos.2013.06.009","article-title":"Adalimumab therapy for refractory childhood uveitis","volume":"17","author":"Bravo-Ljubetic","year":"2013","journal-title":"J. AAPOS"},{"key":"10.1016\/j.jaut.2025.103401_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2021.102278","article-title":"Anterior segment-optical coherence tomography features in Blau syndrome","volume":"34","author":"Concilio","year":"2021","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.jaut.2025.103401_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1211240","article-title":"Tofacitinib, a suppressor of NOD2 expression, is a potential treatment for Blau syndrome","volume":"14","author":"Ueki","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2025.103401_bib21","article-title":"Discovery of new immunomodulatory anticancer thalidomide analogs: desgins suntehsis, biological evaluation and in silico studies","volume":"14","author":"Abdallah","year":"2024","journal-title":"Chem. Biodivers."},{"issue":"1","key":"10.1016\/j.jaut.2025.103401_bib22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12969-021-00634-x","article-title":"Tofacitinib effectiveness in Blau syndrome: a case series of Chinese paediatric patients","volume":"19","author":"Zhang","year":"2021","journal-title":"Pediatr. Rheumatol. Online J."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841125000460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841125000460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T06:22:47Z","timestamp":1746166967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841125000460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":22,"alternative-id":["S0896841125000460"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2025.103401","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of uveitis in Blau syndrome: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2025.103401","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103401"}}